ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0069

Hypertension After Multisystem Inflammatory Syndrome in Children (MIS-C)

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Lehman, Jake R., Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States
  • Shah, Sareen, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States
  • Capone, Christine A., Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States
  • Sethna, Christine B., Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States
Background

MIS-C is an inflammatory condition in children associated with previous SARS-CoV-2 infection that has significant morbidity. Yet, long-term consequences of MIS-C remain unknown. The objective was to determine the prevalence of hypertension (HTN) and pre-HTN during the inpatient stay and post-hospitalization period in children diagnosed with MIS-C.

Methods

A retrospective study of children <18 years of age admitted to a tertiary center with MIS-C between 3/1/2020-2/28/2021 was performed. Children with a minimum of three documented outpatient blood pressures (BPs) were included. All available BPs were averaged and indexed (SBPi/DBPi) to the 95%ile for age, sex and height for the inpatient stay and post-hospitalization period. HTN was defined as mean SBPi or DBPi >1 during the inpatient stay and post-hospitalization period, or taking blood pressure medications for the diagnosis of HTN. Pre-HTN was defined as mean systolic or diastolic BP >90%ile for age, sex and height. Data were analyzed using paired tests and logistic regression.

Results

Among 66 children with MIS-C (mean age 9.4±4.6 years, 59.1% male, 21.2% Black, BMI z-score 0.48±2), 1.5% were hypertensive while hospitalized compared to 18.2% with post-hospitalization HTN (p<0.001). 4.5% were prehypertensive while hospitalized compared to 21.2% of MIS-C children post-hospitalization (p=0.003). Mean SBPi (0.91±0.13 vs. 0.86±0.06, p=0.03) and DBPi (0.87±0.13 vs. 0.77±0.09, p<0.0001) were significantly greater post-hospitalization compared to during hospitalization. In a multivariate model, Black race (OR 10.9 CI 1.6-75.2, p=0.02) and greater BMI z-score (OR 2.9 CI 1.2-7, p=0.02) were significantly associated with post-hospitalization HTN. Acute kidney injury (21.2%), inpatient steroids (86.4%), outpatient steroids (3%), vasoactive support (36.4%) and other clinical/demographic variables were not associated with post-hospitalization HTN (all p>0.05). After hospitalization, no MIS-C patients were started on antihypertensives for the management of HTN. No left ventricular hypertrophy was noted on echocardiography at six months post-hospitalization in those with HTN.

Conclusion

MIS-C appears to be associated with the development of post-hospitalization pediatric HTN and pre-HTN. Follow-up of children who have recovered from MIS-C requires careful BP monitoring and consideration of antihypertensive medication.